J.P. Morgan Private Capital
Overview
J.P. Morgan Private Capital is a growth equity and private debt investment platform of J.P. Morgan Asset Management that focuses on pre-IPO value creation opportunities and middle-market direct lending strategies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Databricks | Aug 2026 | Strategic | Co-investor |
| Lumilens | Aug 2026 | Series C | Co-investor |
| Albert Invent | Feb 2025 | Series A Extension | Lead |
| Enlaza Therapeutics | Apr 2024 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is J.P. Morgan Private Capital based?
J.P. Morgan Private Capital is headquartered in New York City, New York, United States.
When was J.P. Morgan Private Capital founded?
J.P. Morgan Private Capital was founded in 2021.
How many portfolio companies does J.P. Morgan Private Capital have?
J.P. Morgan Private Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in J.P. Morgan Private Capital's portfolio?
Portfolio companies visible on Caplight include Databricks, Lumilens, Albert Invent, Enlaza Therapeutics.
What was J.P. Morgan Private Capital's most recent investment shown here?
J.P. Morgan Private Capital's most recent investment in this portfolio sample was in Databricks in 2026.
What sectors does J.P. Morgan Private Capital focus on?
J.P. Morgan Private Capital focuses on Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Telecommunications & Networking, Enterprise Software.
What company stages does J.P. Morgan Private Capital focus on?
J.P. Morgan Private Capital typically invests at the Early stage.
What is J.P. Morgan Private Capital's AUM?
J.P. Morgan Private Capital's assets under management are estimated between $36.0B and $36.0B.